COVID-19 and PrEPDAP

EFFECTIVE IMMEDIATELY 
Temporary Changes to Pre-Exposure Prophylaxis Drug Assistance Program (PrEPDAP)

In response to Massachusetts Governor Baker's declaration of a State of Emergency to Respond to COVID-19. ( https://www.mass.gov/executive-orders/no-591-declaration-of-a-state-of-emergency-to-respond-to-covid-19), and to ensure that PrEPDAP clients do not experience a gap in coverage or access to medications or pre-exposure prophylaxis (PrEP) during this public health emergency, the following modifications are being made to PrEPDAP enrollment procedures and coverage, effective immediately.                

 

PrEPDAP Policy Modifications:

 

Communicating with CRI 

  • Please continue to contact PrEPDAP through our direct lines (Kevin Herwig 617-502-1737; Katt Baker 617-502-1767). Please contact PrEPDAP via phone for any urgent client cases or clients with specific needs so that we may assist on a case-by-case basis.

  • To submit client applications, forms or information via email, please use our secure email system by:                  

  • Applications, documentation, claims, and forms should be emailed to PrEPDAP as a pdf file to Kevin Herwig kherwig@crine.org  or Katt Baker kbaker@crine.org . Submission via email is preferred to submission by fax

  • You may also reach us via email (Kevin Herwig kherwig@crine.org  or Katt Baker kbaker@crine.org ) with any questions or concerns.       

EXISTING PrEPDAP Client Coverage Extensions

 

PrEPDAP will continue to process and approve applications received for PrEPDAP. Providers should submit applications for clients due to recertify as soon as possible.

 

If providers are unable to submit a recertification application or other required documentation for an EXISTING PrEPDAP client whose PrEPDAP coverage is about to terminate, PrEPDAP can accept a written notification from a provider attesting that a client continues to meet PrEPDAP eligibility requirements. Upon receipt of this notification, the client will receive a provisional approval for an additional three months, at which time the provisional approval may be extended or additional documentation required. Please contact Kevin Herwig at 617-502-1737 or Katt Baker at 617-502-1767 with any questions.  

 

Early Fills of PrEP Medications

PrEPDAP will reimburse pharmacies for prescription charges submitted for "early" fills (prescriptions filled before the usual refill approval date).  

         
60- and 90-day Fills of PrEP Medications
PrEPDAP will reimburse pharmacies for prescription charges submitted for 60- or 90-day fills when prescribed.

 

Communicating with CRI 

  • Please continue to contact PrEPDAP through our direct lines (Kevin Herwig 617-502-1737; Katt Baker 617-502-1767). Please contact PrEPDAP via phone for any urgent client cases or clients with specific needs so that we may assist on a case-by-case basis.

  • To submit client applications, forms or information via email, please use our secure email system by:                  

  • Applications, documentation, claims, and forms should be emailed to PrEPDAP as a pdf file to Kevin Herwig kherwig@crine.org  or Katt Baker kbaker@crine.org . Submission via email is preferred to submission by fax

  • You may also reach us via email (Kevin Herwig kherwig@crine.org  or Katt Baker kbaker@crine.org ) with any questions or concerns.         

 

We appreciate your patience as we work together to best serve the needs of our clients during this challenging time.  

 

Please be well and take care.